Mirati Therapeutics
(NASDAQ) MRTX
Mirati Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$38.19M
Net Income (TTM)
$725.88M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MRTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mirati Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
593
CEO
David D. Meek
Website
www.mirati.comHeadquarters
San Diego, CA 92121, US
MRTX Financials
Key Financial Metrics (TTM)
Gross Margin
95%
Operating Margin
-61%
Net Income Margin
-60%
Return on Equity
-62%
Return on Capital
-73%
Return on Assets
-62%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$11.84M
Operating Income
$759.59M
EBITDA
$756.66M
Operating Cash Flow
$570.57M
Capital Expenditure
$4.85M
Free Cash Flow
$575.42M
Cash & ST Invst.
$1.08B
Total Debt
$51.51M
Mirati Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.40M
+202.0%
Gross Profit
$13.86M
+111.0%
Gross Margin
84.49%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
587
N/A
Net Income
$161.90M
+6.7%
EBITDA
$170.94M
+8.0%
Quarterly Fundamentals
Net Cash
$926.21M
-19.4%
Accounts Receivable
$20.13M
+1094.6%
Inventory
$20.16M
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$8.02M
+11.9%
Return on Assets
-61.60%
N/A
Return on Invested Capital
-72.81%
N/A
Free Cash Flow
$143.75M
-3.4%
Operating Cash Flow
$143.71M
-4.3%